Aruldhas BW, Hoglund RM, Ranjalkar J, Tarning J, Mathew SK, Verghese VP, Bose A, Mathew BS. Optimization of dosing regimens of isoniazid and rifampicin in children with tuberculosis in India. Br J Clin Pharmacol. 2019 Mar;85(3):644-654. doi: 10.1111/bcp.13846. Epub 2019 Jan 17. PMID: 30588647; PMCID: PMC6379231. Link

Ranjalkar J, Mathew SK, Verghese VP, Bose A, Rose W, Gupta D, Fleming DH, Mathew BS. Isoniazid and rifampicin concentrations in children with tuberculosis with either a daily or intermittent regimen: implications for the revised RNTCP 2012 doses in India. Int J Antimicrob Agents. 2018 May;51(5):663-669. doi: 10.1016/j.ijantimicag.2017.12.004. Epub 2017 Dec 11. PMID: 29241821. Link

Gunasekaran K, Amladi A, Mathew SK, Miraclin TA, Iyyadurai R. A case of septicaemic melioidosis: Utility of therapeutic drug monitoring and high-dose meropenem in successful management. Indian J Med Microbiol. 2018 Oct-Dec;36(4):597-599. doi: 10.4103/ijmm.IJMM_18_433. PMID: 30880715.

Abiramalatha T, Mathew SK, Mathew BS, Shabeer MP, Arulappan G, Kumar M, Jayaseelan V, Kuruvilla KA. Continuous infusion versus intermittent bolus doses of fentanyl for analgesia and sedation in neonates: an open-label randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 2019 Jul;104(4):F433-F439. doi: 10.1136/archdischild-2018-315345. Epub 2018 Oct 15. PMID: 30322973.

Aruldhas BW, Hoglund RM, Ranjalkar J, Tarning J, Mathew SK, Verghese VP, Bose A, Mathew BS. Optimization of dosing regimens of isoniazid and rifampicin in children with tuberculosis in India. Br J Clin Pharmacol. 2019 Mar;85(3):644-654. doi: 10.1111/bcp.13846. Epub 2019 Jan 17. PMID: 30588647; PMCID: PMC6379231.

Gopalakrishnan AV, Sunish SC, Mathew BS, Prabha R, Mathew SK. Stability of Vancomycin in Whole Blood. Ther Drug Monit. 2021 Jun 1;43(3):443-444. doi: 10.1097/FTD.0000000000000865. PMID: 33973967. Link

Aruldhas BW, Hoglund RM, Ranjalkar J, Tarning J, Mathew SK, Verghese VP, Bose A, Mathew BS. Optimization of dosing regimens of isoniazid and rifampicin in children with tuberculosis in India. Br J Clin Pharmacol. 2019 Mar;85(3):644-654. doi: 10.1111/bcp.13846. Epub 2019 Jan 17. PMID: 30588647; PMCID: PMC6379231. Link

Ranjalkar J, Mathew SK, Verghese VP, Bose A, Rose W, Gupta D, Fleming DH, Mathew BS. Isoniazid and rifampicin concentrations in children with tuberculosis with either a daily or intermittent regimen: implications for the revised RNTCP 2012 doses in India. Int J Antimicrob Agents. 2018 May;51(5):663-669. doi: 10.1016/j.ijantimicag.2017.12.004. Epub 2017 Dec 11. PMID: 29241821. Link

Gunasekaran K, Amladi A, Mathew SK, Miraclin TA, Iyyadurai R. A case of septicaemic melioidosis: Utility of therapeutic drug monitoring and high-dose meropenem in successful management. Indian J Med Microbiol. 2018 Oct-Dec;36(4):597-599. doi: 10.4103/ijmm.IJMM_18_433. PMID: 30880715.

Abiramalatha T, Mathew SK, Mathew BS, Shabeer MP, Arulappan G, Kumar M, Jayaseelan V, Kuruvilla KA. Continuous infusion versus intermittent bolus doses of fentanyl for analgesia and sedation in neonates: an open-label randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 2019 Jul;104(4):F433-F439. doi: 10.1136/archdischild-2018-315345. Epub 2018 Oct 15. PMID: 30322973.

Aruldhas BW, Hoglund RM, Ranjalkar J, Tarning J, Mathew SK, Verghese VP, Bose A, Mathew BS. Optimization of dosing regimens of isoniazid and rifampicin in children with tuberculosis in India. Br J Clin Pharmacol. 2019 Mar;85(3):644-654. doi: 10.1111/bcp.13846. Epub 2019 Jan 17. PMID: 30588647; PMCID: PMC6379231.

Gopalakrishnan AV, Sunish SC, Mathew BS, Prabha R, Mathew SK. Stability of Vancomycin in Whole Blood. Ther Drug Monit. 2021 Jun 1;43(3):443-444. doi: 10.1097/FTD.0000000000000865. PMID: 33973967. Link

Naik GS, Kodagali R, Tyagi MG, Ernest K, Shanthi M, Mathew SK, Peedicayil J. Inhibition of Spontaneous Contractility of Isolated Caprine Ureter by Flupirtine. Int J Appl Basic Med Res. 2018 Apr-Jun;8(2):116-119. doi: 10.4103/ijabmr.IJABMR_159_17. PMID: 29744325; PMCID: PMC5932919. Link

Mathew SK, Naik GS, Peedicayil J. Inhibition by Benidipine of Contractility of Isolated Proximal and Distal Caprine Ureter. Int J Appl Basic Med Res. 2017 Jul-Sep;7(3):155-159. doi: 10.4103/ijabmr.IJABMR_87_16. PMID: 28904913; PMCID: PMC5590376.

Jacob J, Mathew SK, Chacko RT, Aruldhas BW, Singh A, Prabha R, Mathew BS. Systemic exposure to 5-fluorouracil and its metabolite, 5,6-dihydrofluorouracil, and development of a limited sampling strategy for therapeutic drug management of 5-fluorouracil in patients with gastrointestinal malignancy. Br J Clin Pharmacol. 2021 Mar;87(3):937-945. doi: 10.1111/bcp.14444. Epub 2020 Jul 26. PMID: 32592630.

Mathew, Sumith & A, Blessed & Mathew, Aswathy & Jacob, Jeana & Prabha, Ratna & Mathew, Binu. (2019). Development and validation of indocyanine green assay in human plasma using High-Performance Liquid Chromatography with PDA detector. International Journal of Research in Pharmaceutical Sciences. 10. 1007-1012. 10.26452/ijrps.v10i2.373.

Prabha R, Mathew SK, Joseph A J, Mathew BS. Determination of thiopurine S-methyltransferase activity using reverse-phase high-performance liquid chromatography assay with ultraviolet detection: Reference values for the Indian population. J Pharmacol Pharmacother 2019;10:105-10 Link

Mathew SK, Mathew BS, Neely MN, Naik GS, Prabha R, Jacob GG, K S, Fleming DH. A Nonparametric Pharmacokinetic Approach to Determine the Optimal Dosing Regimen for 30-Minute and 3-Hour Meropenem Infusions in Critically Ill Patients. Ther Drug Monit. 2016 Oct;38(5):593-9. doi: 10.1097/FTD.0000000000000323. PMID: 27454665. Link

Alshaer MH, Maranchick N, Bai C, Maguigan KL, Shoulders B, Felton TW, Mathew SK, Mardini MT, Peloquin CA. Using Machine Learning To Define the Impact of Beta-Lactam Early and Cumulative Target Attainment on Outcomes in Intensive Care Unit Patients with Hospital-Acquired and Ventilator-Associated Pneumonia. Antimicrob Agents Chemother. 2022 Jun 14:e0056322. doi: 10.1128/aac.00563-22. Epub ahead of print. PMID: 35699444.

Mathew BS, Mathew SK, Aruldhas BW, Prabha R, Gangadharan N, David VG, Varughese S, John GT. Analytical and clinical validation of dried blood spot and volumetric absorptive microsampling for measurement of tacrolimus and creatinine after renal transplantation. Clin Biochem. 2022 Jul-Aug;105-106:25-34. doi: 10.1016/j.clinbiochem.2022.04.014. Epub 2022 Apr 28. PMID: 35490728. Link

Reuter SE, Stocker SL, Alffenaar JC, Baldelli S, Cattaneo D, Jones G, Koch BCP, Kocic D, Mathew SK, Molinaro M, Neely M, Sandaradura I, Marriott DJE. Optimal Practice for Vancomycin Therapeutic Drug Monitoring: Position Statement From the Anti-infectives Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Ther Drug Monit. 2022 Feb 1;44(1):121-132. doi: 10.1097/FTD.0000000000000944. PMID: 34882107.

Reuter SE, Stocker SL, Alffenaar JC, Baldelli S, Cattaneo D, Jones G, Koch BCP, Kocic D, Mathew SK, Molinaro M, Neely M, Sandaradura I, Marriott DJE. Optimal Practice for Vancomycin Therapeutic Drug Monitoring: Position Statement From the Anti-infectives Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Ther Drug Monit. 2022 Feb 1;44(1):121-132. doi: 10.1097/FTD.0000000000000944. PMID: 34882107.

Mathew SK, Rao SV, Prabha R, Neely MN, Mathew BS, Aruldhas BW, Veeraraghavan B, Kandasamy S. Model-Informed Rationale for Early Therapeutic Drug Monitoring of Colistin in Critically Ill Patients. J Clin Pharmacol. 2023 Jan;63(1):57-65. doi: 10.1002/jcph.2130. Epub 2022 Aug 24. PMID: 35924629.

Manesh A, Devasagayam E, Bhanuprasad K, Mathew SK, Karthik R, Mathew BS, Varghese GM. Efficacy of Crushed Delayed-Release Posaconazole Tablets in Rhino-Orbito-Cerebral Mucormycosis. Antimicrob Agents Chemother. 2022 Dec 20;66(12):e0108522. doi: 10.1128/aac.01085-22. Epub 2022 Nov 15. PMID: 36377934; PMCID: PMC9765161.

Alshaer MH, Maranchick N, Alexander KM, Manigaba K, Shoulders BR, Felton TW, Mathew SK, Peloquin CA. Beta-lactam target attainment and associated outcomes in patients with bloodstream infections. Int J Antimicrob Agents. 2023 Mar;61(3):106727. doi: 10.1016/j.ijantimicag.2023.106727. Epub 2023 Jan 14. PMID: 36646230.

Wilfred PM, Mathew S, Chacko B, Prabha R, Mathew BS. Estimation of Free Phenytoin Concentration in Critically Ill Patients with Hypoalbuminemia: Direct-measurement vs Traditional Equations. Indian J Crit Care Med 2022; 26 (6):682-687. DOI: 10.5005/jp-journals-10071-24235

Alshaer MH, Maranchick N, Alexander KM, Manigaba K, Shoulders BR, Felton TW, Mathew SK, Peloquin CA. Beta-lactam target attainment and associated outcomes in patients with bloodstream infections. Int J Antimicrob Agents. 2023 Jan 13:106727. doi: 10.1016/j.ijantimicag.2023.106727. Epub ahead of print. PMID: 36646230.

Reuter SE, Stocker SL, Alffenaar JC, Baldelli S, Cattaneo D, Jones G, Koch BCP, Kocic D, Mathew SK, Molinaro M, Neely M, Sandaradura I, Marriott DJE. Optimal Practice for Vancomycin Therapeutic Drug Monitoring: Position Statement From the Anti-infectives Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Ther Drug Monit. 2022 Feb 1;44(1):121-132. doi: 10.1097/FTD.0000000000000944. PMID: 34882107.

Mathew SK, Rao SV, Prabha R, Neely MN, Mathew BS, Aruldhas BW, Veeraraghavan B, Kandasamy S. Model-Informed Rationale for Early Therapeutic Drug Monitoring of Colistin in Critically Ill Patients. J Clin Pharmacol. 2023 Jan;63(1):57-65. Link

Sivamani P, Eriyat V, Mathew SK, Singh A, Aaron R, Chacko RT, Joel A, Prabha R, Mathew BS. Identification of DPYD variants and estimation of uracil and dihydrouracil in a healthy Indian population. Per Med. 2023 Jan;20(1):39-53. doi: 10.2217/pme-2022-0042. Epub 2022 Nov 23. PMID: 36416570.

Alshaer MH, Williams R, Mousa MJ, Alexander KM, Maguigan KL, Manigaba K, Maranchick N, Shoulders BR, Felton TW, Mathew SK, Peloquin CA. Cefepime Daily Exposure and the Associated Impact on the Change in Sequential Organ Failure Assessment Scores and Vasopressors Requirement in Critically Ill Patients Using Repeated-Measures Mixed-Effect Modeling. Crit Care Explor. 2023 Oct 27;5(11):e0993. doi: 10.1097/CCE.0000000000000993. PMID: 38304706; PMCID: PMC10833631.

Mathew, Sumith K et al. “Genetic predisposition and high exposure to colistin in the early treatment period as independent risk factors for colistin-induced nephrotoxicity.” Clinical and translational science vol. 17,3 (2024): e13764. doi:10.1111/cts.13764